Brief: Aequus Pharmaceuticals enters into agreement with Santen Pharmaceutical's unit
13/06/2017 14:07
June 13 (Reuters) - Aequus Pharmaceuticals Inc AQS.V -
* Has entered into an exclusive agreement in Canada with a
unit of Santen Pharmaceutical
* Under agreement, Aequus and Santen will plan to
co-commercialize an undisclosed ophthalmology therapeutic
product
* Aequus Pharmaceuticals - as per agreement, santen will be
responsible for product manufacturing, distribution, co will be
responsible for field activities
* Net product revenues will be split between aequus and
santen over a ten-year term
Source text for Eikon: ID:nMKWyPXFga
Further company coverage: AQS.V
((bangalore.newsroom@thomsonreuters.com;))